Dr. Dipti Agrawal, MD

Dr. Agrawal practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Agrawal's NPI, 1437137189, was assigned on January 4, 2006. Dr. Agrawal graduated from Boston University School Of Medicine in 1996. Dr. Agrawal holds California license C54879.

Dr. Agrawal's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Agrawal's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Agrawal is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Pacific Inpatient Medical Group. Dmand AI also links Dr. Agrawal to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agrawal practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Agrawal's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Agrawal is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Agrawal's licenses on file in 2 states: California and Texas.

Dmand AI lists cold sores or genital herpes, hiv/aids, immune deficiency disease, joint or bone infection and yeast infection among the conditions Dr. Agrawal treats.

CMS data shows 711 Medicare services from Dr. Agrawal across 7 procedure codes in 2024, for 236 Medicare patients. Medicare paid $78,735 for them.

CMS counts 236 Medicare patients who saw Dr. Agrawal in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agrawal's median patient age at 64, with 37% women.

In 2024, Dr. Agrawal wrote 163 Medicare Part D claims for 31 patients. 80% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $99,443 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Agrawal for performance year 2024, reported as part of a group. Dr. Agrawal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Agrawal, published from 2013 to 2016. 2014 was the busiest year, with 2. Dr. Agrawal has published most often in Rare Tumors. Dr. Agrawal's most frequent co-authors are Amit G. Pandya, MD and Paul M. Southern, MD.

CMS Open Payments shows 7 general payments to Dr. Agrawal from 5 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 81% of the total. Insmed, Inc. paid the most, $276.

Dr. Agrawal graduated from Boston University School Of Medicine in 1996.

Dr. Agrawal is in network with 6 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.